The effect of peptide receptor radionuclide therapy (PRRT) on symptoms and tumour burden in patients with metastatic neuroendocrine tumour (NET)

Authors :: John R. Buscombe
Helen Simpson
Sarah Heard
Ashley Shaw
Stalin Abraham
Ruth Casey
Zia Saad
Deborah Pitfield
Ben Challis
Siobhan Whitley
Source :: Endocrine Abstracts.
Publication Year :: 2016
Publisher :: Bioscientifica, 2016.

Subjects :: Oncology
medicine.medical_specialty
Pathology
Peptide receptor
business.industry
Internal medicine
Radionuclide therapy
medicine
In patient
business
Neuroendocrine tumour

Tools